|
BIXT Bioxytran Inc 1445815 |
| Income Statement |
|
Net Income
|
form10-q
|
-392,374 |
| Balance Sheet |
|
Current Assets
|
34,672 |
|
Assets
|
159,008 |
|
Current Liabilities
|
1,243,578 |
|
Liabilities
|
1,243,578 |
|
Equity
|
-1,084,570 |
|
Shares Out
|
177,956,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-98,047 |
|
Investing Cash Flow
|
-17,867 |
| Market Analysis |
Market Cap
|
13,698,623 |
|
Price
|
0.08 |
|
BVPS
|
588.50 |
|
EPS
|
-0.02 |
|
PS
|
0.10 |
|
FCF
|
-115,914 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BIXT documents filed with the SEC.
BIXT Filings
Clear
